Gulfstream Daily Brief

Regulatory intelligence and policy · Issue 024

MHRA issues precautionary recall and updates medicines guidance

Today’s UK regulatory updates span an active medicines recall and core resources for licensing, renewals, exports, and advertising compliance.

By Scott Morvay, Founder October 5, 2026 Official sources linked

MHRA

Specific MOVICOL Plain batches recalled

Norgine Limited is recalling specific batches as a precaution because some units contain incorrect amounts of active ingredients.

Read the official source

MHRA

Advertising investigation decisions published

MHRA published decisions concerning adverts reported as potentially breaching medicines advertising legislation.

Read the official source

MHRA

Electronic export certificate register published

The Department of Health and Social Care and MHRA published the register of electronic export certificates for human medicines.

Read the official source

MHRA

Medicines licensing application resources published

MHRA provided links covering application routes, legal bases, advice, practical procedures, fees, and variations for marketing authorisations.

Read the official source

MHRA

Marketing authorisation renewal guidance published

MHRA set out how to renew marketing authorisations granted through different routes and at different times.

Read the official source

Why this matters

The recall requires attention to affected batches, while the remaining publications consolidate practical reference points across the UK medicines lifecycle. Regulatory teams should use the relevant MHRA materials when handling applications, renewals, exports, and advertising compliance.

Scott Morvay

Founder, Gulfstream Intelligence

This brief provides general regulatory news and educational information. It is not legal or regulatory advice.